Home › Upcoming votes › GT Biopharma, Inc.
The deadline as the proxy statement states it: “Votes submitted through the Internet or by telephone must be received by 11:59 p.m. Eastern Time on November 10, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in GT Biopharma, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | Amendment and restatement of Charter to eliminate obsolete preferred stock sections | Board | For | — |
| 2 | Charter amendment to increase authorized common shares from 25,000,000 to 250,000,000 | Board | For | — |
| 3 | Nasdaq Rule 5635 approval of issuance of 19.99% or more of common stock under Securities Purchase Agreement | Board | For | — |
| 4 | Adjournment of the Special Meeting if necessary Adjournment |
Board | For | — |
From GT Biopharma, Inc.’s Form 8-K, filed July 24, 2025, for the meeting held July 24, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Michael Breen | 99% | Elected |
| Elect Director: Charles J. Casamento | 99% | Elected |
| Elect Director: Hilary Kramer | 99% | Elected |
| Elect Director: David C. Mun-Gavin | 99% | Elected |
| 2. The proposal to ratify the appointment of Weinberg & Company, P.A | 97% | Approved |
| 3. Proposal to approve, on a non-binding advisory basis, the Registrant's executive compensation | 98% | Approved |
| 4. Proposal to approve, pursuant to Rule 5635 of The Nasdaq Stock Market LLC, the issuance of 19.99% or more of the Registrant's outstanding | 98% | Approved |
| 5. The proposal to approve Amendment No | 97% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.